Tender Offers for Elevai Labs Inc.

Form Type: CORRESP

Filing Date: 2024-11-04

Corporate Action: Tender-offer

Type: Update

Accession Number: 000121390024094229

Comments: Elevai Labs Inc. has submitted an amended Schedule TO-I in response to comments from the SEC, regarding their tender offer for up to 15,000,000 shares of Common Stock. The amendment includes clarifications on their willingness to accept tenders from all jurisdictions unless prohibited by law, and revisions to financial disclosures. The Company now explicitly states that all offer conditions will be satisfied or waived by the expiration date, which aligns with SEC regulations to avoid an illusory offer. Significant details include the integration of information from previous offerings of Common Stock and warrants, which were completed shortly before the current tender offer commenced. The implications of recent sales of additional shares on target security holders are also addressed in new risk factors.

Document Link: View Document